Trial Profile

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate-to-Severe Plaque Psoriasis

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 11 Dec 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs D 2570 (Primary)
Indications Plaque psoriasis
Focus Therapeutic Use
Sponsors InventisBio

Most Recent Events

03 Dec 2024 According to an InventisBio Media Release, the complete data from this Phase 2 trial will be presented at upcoming scientific conferences.
03 Dec 2024 Status changed from recruiting to completed as per an InventisBio Media Release.
03 Dec 2024 Primary endpoint (Percentage of subjects with at least 75% improvement in PASI) has been met.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com